Internal Medicine, Endocrinology, Diabetes, & Metabolism · Greensboro, NC
NPI
1477649721
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1002 N Church St, Suite 4000
Greensboro, NC, 27401
Phone (336) 378-1076
Groups this clinician bills Medicare through
Medicare paid, 2024
$79K
7,802 services
Medicare patients, 2024
259
Average age 73
Drug cost, 2024
$2.5M
6,097 prescriptions
Company payments, 2025
$450
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey S Kerr was code 99214 (office e&m - established), 468 times for 225 patients. In total Jeffrey S Kerr billed 7,802 services in 57 codes, and Medicare paid $79K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 468 | 225 | $82.81 | $39K |
| 36415 Venipuncture Blood Collection | Office | 429 | 209 | $8.57 | $3,676 |
| 84443 Clinical Chemistry | Office | 215 | 136 | $16.46 | $3,539 |
| 83036 Blood Count | Office | 205 | 113 | $9.36 | $1,919 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 120 | 76 | $12.13 | $1,456 |
| 95251 Test - Miscellaneous | Office | 106 | 48 | $25.34 | $2,686 |
| 82043 Clinical Chemistry | Office | 72 | 68 | $5.53 | $398 |
| 82570 Clinical Chemistry | Office | 72 | 68 | $4.95 | $357 |
| 84439 Clinical Chemistry | Office | 65 | 30 | $8.84 | $575 |
| 96372 Injection Administration | Office | 62 | 11 | $10.28 | $637 |
| 80061 Clinical Chemistry | Office | 56 | 56 | $12.69 | $711 |
| 80053 Clinical Chemistry | Office | 48 | 46 | $10.35 | $497 |
| 82565 Clinical Chemistry | Office | 47 | 40 | $4.84 | $227 |
| 85025 Blood Count | Office | 39 | 31 | $7.61 | $297 |
| 80076 Clinical Chemistry | Office | 33 | 23 | $7.82 | $258 |
By year: 2022 $81K for 9,458 services; 2023 $75K for 8,809 services; 2024 $79K for 7,802 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 429 | 209 | $8.57 | $3,676 |
| 84443 Clinical Chemistry | 215 | 136 | $16.46 | $3,539 |
| 83036 Blood Count | 205 | 113 | $9.36 | $1,919 |
| 82570 Clinical Chemistry | 72 | 68 | $4.95 | $357 |
| 82043 Clinical Chemistry | 72 | 68 | $5.53 | $398 |
| 84439 Clinical Chemistry | 65 | 30 | $8.84 | $575 |
| 80061 Clinical Chemistry | 56 | 56 | $12.69 | $711 |
| 80053 Clinical Chemistry | 48 | 46 | $10.35 | $497 |
| 82565 Clinical Chemistry | 47 | 40 | $4.84 | $227 |
| 85025 Blood Count | 39 | 31 | $7.61 | $297 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey S Kerr prescribed most often to Medicare patients was Levothyroxine Sodium, with 988 prescriptions and refills. In total Jeffrey S Kerr wrote 6,097 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 988 | 2,250 | 207 | $9,579 |
| Jardiance Empagliflozin | 264 | 486 | 63 | $285K |
| Synthroid Levothyroxine Sodium | 260 | 612 | 59 | $26K |
| Metformin Hcl Er Metformin Hcl | 258 | 618 | 73 | $3,718 |
| Trulicity Dulaglutide | 252 | 440 | 58 | $436K |
| Ozempic Semaglutide | 241 | 362 | 55 | $338K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 218 | 480 | 61 | $43K |
| Farxiga Dapagliflozin Propanediol | 203 | 365 | 43 | $200K |
| Atorvastatin Calcium Generic | 198 | 538 | 50 | $2,143 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 169 | 444 | 69 | $18K |
| Hydrocortisone Generic | 161 | 305 | 31 | $6,068 |
| Losartan Potassium Generic | 128 | 276 | 29 | $1,371 |
| Rosuvastatin Calcium Generic | 112 | 281 | 30 | $1,147 |
| Metformin Hcl Generic | 106 | 281 | 26 | $865 |
| Humalog Kwikpen U-100 Insulin Lispro | 100 | 225 | 32 | $34K |
Brand drugs: 3,227 claims; generic drugs: 2,397 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey S Kerr $450 ($450 in general payments such as food, travel and fees) from 14 companies. The largest payer was Mannkind Corporation with $101.
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation MNKD | 5 | $101 |
| Sanofi-Aventis U.S. LLC SNY | 2 | $58.96 |
| GlaxoSmithKline, LLC. GSK | 2 | $43.63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35.75 |
| Lilly USA, LLC LLY | 2 | $31.13 |
| Pfizer Inc. PFE | 1 | $30.23 |
| Corcept Therapeutics CORT | 1 | $27.84 |
| Esperion Therapeutics, Inc. ESPR | 1 | $23.66 |
| Rhythm Pharmaceuticals, Inc. RYTM | 1 | $18.04 |
| Inspire Medical Systems, Inc. INSP | 1 | $17.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.